XML 20 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Comprehensive (Loss) Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues        
Product sales, net $ 5,699 $ 6,236
Royalty revenue 3,501 126 6,020 1,776
Collaborative and other research and development 4,262 5,162 11,350 35,643
Total revenues 7,763 10,987 17,370 43,655
Expenses        
Cost of products sold 1,346 1,361
Research and development 14,105 20,067 48,850 53,711
General and administrative 2,756 2,731 8,692 10,326
Royalty 143 5 247 507
Total operating expenses 17,004 24,149 57,789 65,905
Loss from operations (9,241) (13,162) (40,419) (22,250)
Interest and other income 109 134 695 367
Interest expense (1,465) (1,241) (4,356) (3,862)
(Loss) gain on foreign currency derivative (931) (352) (6,561) 861
Net loss $ (11,528) $ (14,621) $ (50,641) $ (24,884)
Basic and diluted net loss per common share (in dollars per share) $ (0.16) $ (0.20) $ (0.69) $ (0.34)
Weighted average shares outstanding (in shares) 73,734 73,262 73,677 72,752
Unrealized (loss) gain on available for sale investments $ (24) $ 91 $ 228 $ 129
Comprehensive loss $ (11,552) $ (14,530) $ (50,413) $ (24,755)